|
Volumn 1, Issue 2, 2009, Pages 177-179
|
Immunotherapy at the ACAAI Annual Meeting
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLERGEN;
GRASS POLLEN VACCINE;
HOUSE DUST ALLERGEN;
IMMUNOGLOBULIN G ANTIBODY;
PLACEBO;
POLLINEX QUATRO;
RAGWEED ANTIGEN;
RECOMBINANT VACCINE;
UNCLASSIFIED DRUG;
ALLERGIC ASTHMA;
ALLERGIC RHINITIS;
ALLERGY;
ANAPHYLAXIS;
ANTIBODY RESPONSE;
ASTHMA;
ATOPIC DERMATITIS;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG ADMINISTRATION ROUTE;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
EUROPE;
HUMAN;
HYPOTENSION;
IMMUNIZATION;
IMMUNOTHERAPY;
MEXICO;
MOUTH DISCOMFORT;
NONHUMAN;
PHLEUM PRATENSE;
PRIORITY JOURNAL;
SAFETY;
SUBLINGUAL IMMUNOTHERAPY;
TABLET FORMULATION;
UNITED STATES;
URTICARIA;
ADMINISTRATION, SUBLINGUAL;
ALLERGY AND IMMUNOLOGY;
ANIMALS;
AUTOIMMUNITY;
CLINICAL TRIALS AS TOPIC;
DESENSITIZATION, IMMUNOLOGIC;
HUMANS;
HYPERSENSITIVITY;
PORTUGAL;
UNITED STATES;
|
EID: 77953465516
PISSN: 1750743X
EISSN: None
Source Type: Journal
DOI: 10.2217/IMT.09.1 Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|